A*STAR Singapore Immunology Network (A*STAR SIgN)

Region-specific stem cells may not only act as starting points for colorectal cancer, but also offer new clues for early detection and treatment.

As the Chairman of Singapore’s lead R&D public sector agency, Chorh Chuan Tan outlines A*STAR’s strategic role within a new phase of national strategic priorities in research, innovation and enterprise.

At A*STAR, precision medicine and population health are bridging disciplines to shed new light on facets of human development and well-being, enabling targeted early interventions to enhance the healthspans of Asian populations.

Comparing hypothalamic networks in zebrafish and mice reveals evolutionarily conserved neuronal pathways that regulate appetite across vertebrates.

An anti-hypertension drug could potentially be repurposed as a more affordable treatment for liver cancer.

Breast milk is supercharged with antibodies that promote healthy gut immunity in babies.

Disrupting the binding of a key protein pair in immune cells could help avert deadly allergic responses.

A deep dive into the skin barrier uncovers the critical role immune cells play in structural reinforcement and wound healing.

In recognition of their research excellence, leadership and impact both locally and globally, ten leading A*STAR researchers have been awarded the A*STAR Distinguished Fellowship and Fellowships.

A new spatial multi-omics tool merges different levels of biological data from the same tissue sample to better differentiate finer details at different health states.

A large-scale gut microbiome study in elderly Singaporeans reveals new insights into the role of our resident microbes in healthy ageing.

Researchers uncovered how specialised stem cells act as building blocks for the esophagus, shaping its development and offering insights into treating related diseases.